The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the blood of someone who doesn’t have the disease. When used alongside the ...
A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...
Pancreatic cancer is one of the deadliest and most difficult-to-detect forms of cancer. It kills nearly half a million people annually and has a five-year survival rate of less than 15 percent. The ...
The study demonstrates that PAC-MANN-1 outperforms the widely used CA 19-9 biomarker, offering greater accuracy in detecting all stages of PDAC. The assay is particularly promising for identifying ...
In recent study, PAC-MANN identified pancreatic ductal adenocarcinoma samples with 98 percent specificity and 73 percent sensitivity across all stages.
The new blood-based assay PAC-MANN-1 (protease activity–based cancer marker using magnetic nanosensor-1) identified pancreatic ductal adenocarcinoma (PDAC) across all stages with high ...
Targeting IgE with a protease such as S‑8484 offers the unique ability to directly degrade serum IgE antibody and cleave IgE expressed on B cells therefore targeting multiple mechanisms of ...
Pathogens can produce analogous proteases to subvert the host immune response. The balance in activity between a protease and its inhibitor can tune the immune response or cause damage as a result ...
We speculated that the low catalytic activity of the native p6 pol-protease precursor that is observed preceding its maturation may be an intrinsic feature of the dimeric precursor. Alternatively ...
“Production of proteases is a hallmark of cancer progression and circulating protease activity may inform diagnosis of certain cancers,” researchers wrote in the journal, Science Translational ...
and its second immunoglobulin protease pipeline candidate engineered to have potent enzymatic activity with optimized therapeutic properties. The in vitro and in vivo data supporting S‑8484 are ...